| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 0 |
| Log P | RDKit | 0 |
| Topological polar surface area (Å2) | RDKit | |
| Number of hydrogen bond acceptors | RDKit | |
| Number of hydrogen bond donors | RDKit | |
| Number of carbon atoms | RDKit | |
| Number of heavy atoms | RDKit | |
| Number of heteroatoms | RDKit | |
| Number of nitrogen atoms | RDKit | |
| Number of sulfur atoms | RDKit | |
| Number of chiral carbon atoms | RDKit | |
| Stereochemical complexity | RDKit | 0 |
| Number of sp hybridized carbon atoms | RDKit | |
| Number of sp2 hybridized carbon atoms | RDKit | |
| Number of sp3 hybridized carbon atoms | RDKit | |
| Shape complexity | RDKit | |
| Number of rotatable bonds | RDKit | |
| Number of aliphatic carbocycles | RDKit | |
| Number of aliphatic heterocycles | RDKit | |
| Number of aliphatic rings | RDKit | |
| Number of aromatic carbocycles | RDKit | |
| Number of aromatic heterocycles | RDKit | |
| Number of aromatic rings | RDKit | |
| Total number of rings | RDKit | |
| Number of saturated carbocycles | RDKit | |
| Number of saturated heterocycles | RDKit | |
| Number of saturated rings | RDKit | |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit |
| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 2 |
| Lipinski’s rule of 5 | RDKit | Failed |
| Number of Ghose rule violations | RDKit | 2 |
| Ghose rule | RDKit | Failed |
| Veber rule | RDKit | Bad |
| Egan rule | RDKit | Bad |
| GSK 4/400 rule | RDKit | Bad |
| Pfizer 3/75 rule | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.22 |
| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Poorly soluble |
| Solubility class [Silicos-IT] | SwissADME | Poorly soluble |
| Blood Brain Barrier permeation | SwissADME | No |
| Gastrointestinal absorption | SwissADME | Low |
| Log Kp (Skin permeation, cm/s) | SwissADME | -5.25 |
| Number of PAINS structural alerts | SwissADME | 0.0 |
| Number of Brenk structural alerts | SwissADME | 1.0 |
| CYP1A2 inhibitor | SwissADME | No |
| CYP2C19 inhibitor | SwissADME | Yes |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | No |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | No |
| Protein identifier | HGNC symbol | Combined score from STITCH database |
|---|---|---|
| ENSP00000202788 | 857 | |
| ENSP00000221930 | TGFB1 | 800 |
| ENSP00000225831 | CCL2 | 800 |
| ENSP00000228307 | PXN | 800 |
| ENSP00000229794 | MAPK14 | 731 |
| ENSP00000245414 | IRF1 | 800 |
| ENSP00000251849 | RAF1 | 725 |
| ENSP00000260433 | CYP19A1 | 700 |
| ENSP00000263125 | PRKCQ | 779 |
| ENSP00000264657 | STAT3 | 800 |
| ENSP00000267163 | RB1 | 700 |
| ENSP00000270202 | AKT1 | 744 |
| ENSP00000302486 | MAP2K1 | 733 |
| ENSP00000302665 | IGF1 | 800 |
| ENSP00000308541 | F2 | 786 |
| ENSP00000311032 | CASP3 | 770 |
| ENSP00000327251 | NOS2 | 786 |
| ENSP00000330237 | CASP9 | 700 |
| ENSP00000331602 | PRKCD | 840 |
| ENSP00000332973 | SMAD3 | 800 |
| ENSP00000337459 | NOS1 | 786 |
| ENSP00000354558 | MTOR | 721 |
| ENSP00000355330 | TGM2 | 800 |
| ENSP00000355759 | PARP1 | 700 |
| ENSP00000356436 | PLA2G4A | 800 |
| ENSP00000362082 | CCND3 | 800 |
| ENSP00000376436 | ETS1 | 826 |
| ENSP00000441691 | ITGAM | 800 |
